News & Perspective

Dec 19, 2008

Dec 19, 2008

With H1N1 resistance, CDC changes advice on flu drugs

(CIDRAP News) – Increased resistance to oseltamivir (Tamiflu), the leading influenza drug, has prompted federal health officials to change their advice about flu treatment, saying clinicians for now should consider using zanamivir (Relenza) or a combination of two drugs for patients suspected of having influenza A.

Sep 22, 2009

Sep 22, 2009

Business conference airs challenges of H1N1 vaccine campaign

(CIDRAP News) – With the second wave of the H1N1 influenza virus now hitting, much of the response toe the pandemic is focused on the development and distribution of an effective vaccine, a project that poses many challenges and uncertainties.

Nov 25, 2009

Nov 25, 2009

CDC warns about rise in serious pneumococcal disease

(CIDRAP News) – In a worrisome but not unexpected pandemic-related development, the US Centers for Disease Control and Prevention (CDC) said today that it is seeing a spike in serious pneumococcal disease, particularly in younger patients.

Oct 18, 2010

Oct 18, 2010

CDC: Flu activity low, with all three types in the mix

(CIDRAP News) – Flu is circulating at low levels in the United States, with the 2009 H1N1 virus appearing sporadically along with H3N2 and influenza B strains, the US Centers for Disease Control and Prevention (CDC) said in its first official surveillance report of the new season.

May 09, 2018

May 09, 2018

News Scan for May 09, 2018

More romaine E coli cases
Predicting pandemic severity
Lassa fever cases
HPV vaccine meta-analysis

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»